http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TR-201722630-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ffbe71cb54b92414ad178bb647126c1d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
filingDate 2017-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c42e3780ef7ea3241e8a3d8eabd2e4ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b916b7b625bea15e747b6227c244a68d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6637b24d9c78168dc31848682211b7db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c46442fbb184b4b12ee26b36d6b9e43e
publicationDate 2019-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TR-201722630-A2
titleOfInvention PHARMACEUTICAL TABLET COMPOSITIONS OF DABIGATRAN
abstract The present invention relates to pharmaceutical tablet compositions for oral administration containing dabigatran etexilate free base or pharmaceutically acceptable salts of dabigatran etexilate and at least one pharmaceutically acceptable excipient.
priorityDate 2017-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419541365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135565674
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419479912
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216210

Total number of triples: 21.